Выпуск
Pharmaceutical Executive Daily: FDA Approves Fayuvi
Pharmaceutical Executive · 18 сентября 2026 г. · 3 мин
FDA approves Ultragenyx's Fayuvi as the first treatment for Sanfilippo syndrome type A, Lisata Therapeutics acquires Marea Therapeutics as mAbxience partners with Sandoz on a hemophilia A biosimilar, and Joe Cunningham argues that executive drug-pricing deals alone won't fix costs.